Medical Properties Trust, Inc. (MPT) is a prominent real estate investment trust (REIT) headquartered in the United States, with a significant presence in key operational regions across North America and Europe. Founded in 2003, MPT has established itself as a leader in the healthcare real estate sector, focusing primarily on acquiring and managing high-quality hospital facilities. The company’s unique approach involves long-term leases with leading healthcare operators, ensuring stable cash flows and a robust portfolio. MPT's commitment to providing essential healthcare infrastructure has positioned it as a trusted partner in the industry, with notable achievements including a diverse portfolio of properties across various healthcare sectors. With a strong market position, Medical Properties Trust continues to drive innovation and growth in the healthcare real estate landscape.
How does Medical Properties Trust's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Medical Properties Trust's score of 29 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Medical Properties Trust reported total carbon emissions of approximately 354,844,000 kg CO2e. This figure includes 132,276,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 222,568,000 kg CO2e from Scope 2 emissions, which are indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Additionally, the company recorded 1,132,000 kg CO2e in Scope 3 emissions, specifically from business travel. Comparatively, in 2022, the total emissions were about 341,282,000 kg CO2e, with Scope 1 emissions at 130,581,000 kg CO2e and Scope 2 emissions at 210,701,000 kg CO2e. The Scope 3 emissions for that year were 1,059,000 kg CO2e. This indicates a slight increase in total emissions from 2022 to 2023. Medical Properties Trust has not set specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi). The company does not appear to inherit emissions data from a parent organisation, as it operates independently in this regard. Overall, while Medical Properties Trust has disclosed its emissions data across all relevant scopes, it currently lacks formal climate commitments or reduction strategies.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 4,733,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 679,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 645,000 | 0,000,000 | 0,000,000 |
Medical Properties Trust's Scope 3 emissions, which increased by 7% last year and increased by approximately 76% since 2021, demonstrating supply chain emissions tracking. Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Business Travel" representing nearly all of their reported Scope 3 footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medical Properties Trust has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
